All Stories

  1. Association Between CTSG Variants and Persistent Postoperative Pain After Cardiac Surgery

    Article • Anesthesia & Analgesia, May 2026, Wolters Kluwer Health

    Dr Victor Asensi

  2. Hodgkin and non‐Hodgkin lymphomas in the post‐antiretroviral therapy era according to HIV virological suppression

    Article • HIV Medicine, May 2026, Wiley

    Dr Victor Asensi

  3. Y181C ‐associated virologic failure during long‐acting injectable cabotegravir/Rilpivirine in a patient engaged in intensive intravenous Chemsex

    Article • HIV Medicine, January 2026, Wiley

    Dr Victor Asensi

  4. Elevated Plasma GDF-15 Levels Are Associated with Aging, Multimorbidity, and Tobacco Exposure in People with HIV

    Article • Infectious Diseases and Therapy, January 2026, Springer Science + Business Media

    Dr Victor Asensi

  5. Access to Specialized Medical Training in Spain and Determinants of Failure in the National Entrance Examination: Econometric Modeling Study

    Article • JMIR Formative Research, December 2025, JMIR Publications Inc.

    Dr Victor Asensi

  6. Markers of Inflammation and Immune Dysfunction and Non-AIDS Cancer Risk in Adults With HIV

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, July 2025, Wolters Kluwer Health

    Dr Victor Asensi

  7. Epidemiological, Clinical and Analytical Features in Lyme Borreliosis Patients Seropositive for Babesia divergens/venatorum

    Article • Microorganisms, June 2025, MDPI AG

    Dr Victor Asensi

  8. Depicting gouty arthritis at the Royal Court of Spain: the case of Pablo de Valladolid (1587–1648), the jester of King Philip IV

    Article • Rheumatology International, April 2025, Springer Science + Business Media

    Dr Victor Asensi

  9. Real-world Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Comparison With Other Regimens in People With HIV Starting Therapy With AIDS-Defining Conditions: Results From the CoRIS Cohort—The ACTUAS II Study

    Article • Clinical Infectious Diseases, March 2025, Oxford University Press (OUP)

    Dr Victor Asensi

  10. Extended sequential intravenous and oral antimicrobial therapy improves cure rate in postoperative intracranial neurosurgical infections: a Spanish multicenter retrospective study

    Article • BMC Infectious Diseases, November 2024, Springer Science + Business Media

    Dr Victor Asensi

  11. Otosyphilis: Two case reports and review of the English and Spanish literature of the last 24 years

    Article • Acta Otorrinolaringologica (English Edition), November 2024, Elsevier

    Dr Victor Asensi

  12. No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients

    Article • Scientific Reports, March 2024, Springer Science + Business Media

    Dr Victor Asensi

  13. Noninvasive Liver Fibrosis Markers in the Evaluation of Fibrosis Regression After Direct-Acting Antiviral Therapy

    Article • The Journal of Infectious Diseases, February 2024, Oxford University Press (OUP)

    Dr Victor Asensi

  14. Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up

    Article • Journal of Cancer Research and Clinical Oncology, November 2023, Springer Science + Business Media

    Dr Victor Asensi

  15. COVID-19 and Access to Medical Professional Careers: Does Gender Matter?

    Article • International Journal of Environmental Research and Public Health, July 2023, MDPI AG

    Dr Victor Asensi

  16. Retrospective study of the epidemiological risk and serological diagnosis of human babesiosis in Asturias, Northwestern Spain

    Article • Parasites & Vectors, June 2023, Springer Science + Business Media

    Dr Victor Asensi

  17. Correction: Chronic Gastro-Duodenal Ulcerative Disease and the Death of Father Stephan Schätzl from Viechtwang (Austria)

    Article • Journal of Religion and Health, March 2023, Springer Science + Business Media

    Dr Victor Asensi

  18. HIV medical care interruption among people living with HIV in Spain, 2004–2020

    Article • AIDS, March 2023, Wolters Kluwer Health

    Dr Victor Asensi

  19. Chronic Gastro-Duodenal Ulcerative Disease and the Death of Father Stephan Schätzl from Viechtwang (Austria)

    Article • Journal of Religion and Health, March 2023, Springer Science + Business Media

    Dr Victor Asensi

  20. Author Correction: IL-1 β gene (+ 3954 C/T, exon 5, rs1143634) and NOS2 (exon 22) polymorphisms associate with early aseptic loosening of arthroplasties

    Article • Scientific Reports, December 2022, Springer Science + Business Media

    Dr Victor Asensi

  21. IL-1 β gene (+3954 C/T, exon 5, rs1143634) and NOS2 (exon 22) polymorphisms associate with early aseptic loosening of arthroplasties

    Article • Scientific Reports, November 2022, Springer Science + Business Media

    Dr Victor Asensi

  22. From Molière to SARS-CoV-2: How Medicine has changed

    Article • La Revue de Médecine Interne, August 2022, Elsevier

    Dr Victor Asensi

  23. Remdesivir in Very Old Patients (≥80 Years) Hospitalized with COVID-19: Real World Data from the SEMI-COVID-19 Registry

    Article • Journal of Clinical Medicine, June 2022, MDPI AG

    Dr Victor Asensi

  24. Use of Generic Antiretroviral Drugs and Single-Tablet Regimen De-Simplification for the Treatment of HIV Infection in Spain

    Article • AIDS Research and Human Retroviruses, June 2022, SAGE Publications

    Dr Victor Asensi

  25. War, pandemic and vaccination – Upcoming health problems by the refugee wave in Europe?

    Article • Vaccine, May 2022, Elsevier

    Dr Victor Asensi

  26. 24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy

    Article • Scientific Reports, March 2022, Springer Science + Business Media

    Dr Victor Asensi

  27. Vaccination as a nativity scene

    Article • Internal and Emergency Medicine, March 2022, Springer Science + Business Media

    Dr Victor Asensi

  28. Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19

    Article • PLOS One, January 2022, PLOS

    Dr Victor Asensi

  29. Correction to: Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS‑CoV‑2 infectivity

    Article • Clinical Epigenetics, November 2021, Springer Science + Business Media

    Dr Victor Asensi

  30. Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort

    Article • Clinical Microbiology and Infection, November 2021, Elsevier

    Dr Victor Asensi

  31. Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity

    Article • Clinical Epigenetics, October 2021, Springer Science + Business Media

    Dr Victor Asensi

  32. Hydroxy-chloroquine to treat COVID-19 – infected patients: Some lessons from medical anthropology and history of medicine

    Article • Ethics Medicine and Public Health, October 2020, Elsevier

    Dr Victor Asensi

  33. Why paleomedicine is useful for medical education

    Article • Postgraduate Medical Journal, May 2020, Oxford University Press (OUP)

    Dr Victor Asensi

  34. Factors associated with sepsis development in 606 Spanish adult patients with cellulitis

    Article • BMC Infectious Diseases, March 2020, Springer Science + Business Media

    Dr Victor Asensi

  35. Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21

    Article • Journal of Clinical Medicine, March 2020, MDPI AG

    Dr Victor Asensi

  36. Tudor military surgery and the management of Sir Martin Frobisher's gunshot wound: Comparison with current treatment

    Article • Injury, March 2020, Elsevier

    Dr Victor Asensi

  37. Ethambutol-resistant Mycobacterium kansasii cervical lymphadenitis in an immunocompetent adult patient: A case report and literature review

    Article • Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, February 2020, Elsevier

    Dr Victor Asensi

  38. Unilateral cryptorchidism in a 16th Florentine painting

    Article • The Journal of Maternal-Fetal & Neonatal Medicine, December 2019, Taylor & Francis

    Dr Victor Asensi

  39. The N125S polymorphism in the cathepsin G gene (rs45567233) is associated with susceptibility to osteomyelitis in a Spanish population

    Article • PLOS One, October 2019, PLOS

    Dr Victor Asensi

  40. Decreasing rates of acute myocardial infarction in people living with HIV: a nationwide cohort study in Spain, 2004-2015

    Article • HIV Medicine, April 2018, Wiley

    Dr Victor Asensi

  41. Malthus Mysterious Orofacial Cleft Correction

    Article • The Cleft Palate-Craniofacial Journal, March 2018, SAGE Publications

    Dr Victor Asensi

  42. Clinical, epidemiological and treatment failure data among HIV-1 non-B-infected patients in the Spanish AIDS Research Network Cohort

    Article • Enfermedades Infecciosas y Microbiología Clínica, June 2016, Elsevier

    Dr Victor Asensi

  43. Factors associated with long-term CD4 cell recovery in HIV-infected patients on successful antiretroviral therapy

    Article • HIV Medicine, January 2016, Wiley

    Dr Victor Asensi

  44. The effect of gender and genetic polymorphisms on matrix metalloprotease (MMP) and tissue inhibitor (TIMP) plasma levels in different infectious and non-infectious conditions

    Article • Clinical & Experimental Immunology, September 2015, Wiley

    Dr Victor Asensi

  45. Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir

    Article • HIV Medicine, September 2015, Wiley

    Dr Victor Asensi

  46. HIV/antiretroviral therapy–related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasma

    Article • Clinical Microbiology and Infection, July 2015, Elsevier

    Dr Victor Asensi

  47. CD4+CD28null T lymphocytes resemble CD8+CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients

    Article • Journal of Leukocyte Biology, June 2015, Society for Leukocyte Biology

    Dr Victor Asensi

  48. Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics

    Article • World Journal of Virology, January 2015, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Victor Asensi

  49. Differential Body Composition Effects of Protease Inhibitors Recommended for Initial Treatment of HIV Infection: A Randomized Clinical Trial

    Article • Clinical Infectious Diseases, November 2014, Oxford University Press (OUP)

    Dr Victor Asensi

  50. Endothelial (NOS3 E298D) and inducible (NOS2 exon 22) nitric oxide synthase polymorphisms, as well as plasma NOx, influence sepsis development

    Article • Nitric Oxide, November 2014, Elsevier

    Dr Victor Asensi

  51. Role of plasma matrix-metalloproteases (MMPs) and their polymorphisms (SNPs) in sepsis development and outcome in ICU patients

    Article • Scientific Reports, May 2014, Nature

    Dr Victor Asensi

  52. Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients

    Article • Journal of Antimicrobial Chemotherapy, May 2014, Oxford University Press (OUP)

    Dr Victor Asensi

  53. Immune Reconstitution Inflammatory Syndrome-Unmasking Endophthalmic, Lymphadenopathic, and Neuromeningeal Cryptococcosis in an HIV-Infected Patient Starting Highly Active Antiretroviral Therapy

    Article • AIDS Research and Human Retroviruses, May 2014, Mary Ann Liebert Inc

    Dr Victor Asensi

  54. Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS)

    Article • Journal of Antimicrobial Chemotherapy, February 2014, Oxford University Press (OUP)

    Dr Victor Asensi

  55. Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs

    Article • HIV Medicine, November 2013, Wiley

    Dr Victor Asensi, Dr. Vicente Soriano

  56. Efficacy and Tolerability of Darunavir/Ritonavir in Combination with Abacavir/Lamivudine: An Option in Selected HIV-Infected Patients

    Article • HIV Clinical Trials, October 2013, Taylor & Francis

    Dr Victor Asensi

  57. tPA Alu (I/D) Polymorphism Associates With Bacterial Osteomyelitis

    Article • The Journal of Infectious Diseases, April 2013, Oxford University Press (OUP)

    Dr Victor Asensi

  58. Euler's Right Eye: The Dark Side of a Bright Scientist

    Article • Clinical Infectious Diseases, March 2013, Oxford University Press (OUP)

    Dr Victor Asensi

  59. The Effect of Unsuccessful Treatment with Peginterferon and Ribavirin on the Liver Fibrosis Course of HIV/HCV-Coinfected Patients

    Article • Current HIV Research, November 2012, Bentham Science Publishers

    Dr Victor Asensi

  60. Course of Liver Fibrosis in HIV-Hepatitis C Virus-Coinfected Patients Depending on the Response to Hepatitis C Therapy

    Article • AIDS Research and Human Retroviruses, July 2012, Mary Ann Liebert Inc

    Dr Victor Asensi

  61. Comparison of High Ribavirin Induction Versus Standard Ribavirin Dosing, Plus Peginterferon-  for the Treatment of Chronic Hepatitis C in HIV-Infected Patients: The PERICO Trial

    Article • The Journal of Infectious Diseases, July 2012, Oxford University Press (OUP)

    Dr Victor Asensi, Dr. Vicente Soriano

  62. Definition of Advanced Age in HIV-Infection: Looking for an Age Cut-Off.

    Article • AIDS Research and Human Retroviruses, May 2012, Mary Ann Liebert Inc

    Dr Victor Asensi, Dr. Vicente Soriano

  63. Didanosine (ddI) associates with increased liver fibrosis in adult HIV-HCV coinfected patients

    Article • Journal of Viral Hepatitis, March 2012, Wiley

    Dr Victor Asensi

  64. Infección combinada por virus de la inmunodeficiencia humana y enfermedad de Chagas tratada satisfactoriamente con benznidazol y una pauta de tratamiento antirretroviral basada en raltegravir: descripción de un caso

    Article • Medicina Clínica, September 2011, Elsevier

    Dr Victor Asensi

  65. The IL-1β (+3953 T/C) gene polymorphism associates to symptomatic lumbar disc herniation

    Article • European Spine Journal, August 2011, Springer Science + Business Media

    Dr Victor Asensi

  66. Gender Differences in Liver Fibrosis and Hepatitis C Virus-Related Parameters in Patients Coinfected with Human Immunodeficiency Virus

    Article • Current HIV Research, July 2011, Bentham Science Publishers

    Dr Victor Asensi

  67. Immunological Status Does Not Influence Hepatitis C Virus or Liver Fibrosis in HIV-Hepatitis C Virus-Coinfected Patients

    Article • AIDS Research and Human Retroviruses, April 2011, Mary Ann Liebert Inc

    Dr Victor Asensi

  68. No Relationship Between TNF-α Genetic Variants and Combination Antiretroviral Therapy-Related Lipodystrophy Syndrome in HIV Type 1-Infected Patients: A Case-Control Study and a Meta-Analysis

    Article • AIDS Research and Human Retroviruses, February 2011, Mary Ann Liebert Inc

    Dr Victor Asensi

  69. Factors associated with liver fibrosis in intravenous drug users coinfected with HIV and HCV

    Article • Antiviral Therapy, January 2011, International Medical Press

    Dr Victor Asensi

  70. Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy

    Article • Journal of the International AIDS Society, November 2010, Wiley

    Dr Victor Asensi, Dr. Vicente Soriano

  71. Evaluation of the possible influence of hepatitis C virus and liver fibrosis on HIV type 1 immunological and virological outcomes

    Article • HIV Medicine, October 2010, Wiley

    Dr Victor Asensi

  72. The MMP1 (−16071G/2G) single nucleotide polymorphism associates with the HAART-related lipodystrophic syndrome

    Article • AIDS, October 2010, Wolters Kluwer Health

    Dr Victor Asensi

  73. Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions

    Article • HIV Medicine, September 2010, Wiley

    Dr Victor Asensi

  74. Asociación entre el polimorfismo genético de la interleucina-1β (3953 T/C) y la hernia discal lumbar sintomática

    Article • Revista Española de Cirugía Ortopédica y Traumatología, July 2010, Elsevier

    Dr Victor Asensi

  75. Screening for Chagas' disease in HIV-positive immigrants from endemic areas

    Article • Epidemiology and Infection, June 2010, Cambridge University Press

    Dr Victor Asensi

  76. Meropenem monotherapy is as effective as and safer than imipenem to treat brain abscesses

    Article • International Journal of Antimicrobial Agents, March 2010, Elsevier

    Dr Victor Asensi

  77. Association between the genetic polymorphism of interleukin-1ß (3953 T/C) and symptomatic lumbar herniated disc

    Article • Revista Española de Cirugía Ortopédica y Traumatología (English Edition), January 2010, Elsevier

    Dr Victor Asensi

  78. Association of HIV transmission categories with sociodemographic, viroimmunological and clinical parameters of HIV-infected patients

    Article • Epidemiology and Infection, November 2009, Cambridge University Press

    Dr Victor Asensi

  79. A Functional Polymorphism inMMP1Could Influence Osteomyelitis Development

    Article • Journal of Bone and Mineral Research, October 2009, Wiley

    Dr Victor Asensi

  80. Abscesos abdominales y retroperitoneales en paciente con carcinoma vesical en tratamiento con bacilo de Calmette y Guérin

    Article • Enfermedades Infecciosas y Microbiología Clínica, October 2009, Elsevier

    Dr Victor Asensi

  81. CD8dim and NKG2D Expression Defines Related Subsets of CD4+ T cells in HIV-Infected Patients With Worse Prognostic Factors

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2009, Wolters Kluwer Health

    Dr Victor Asensi, Prof. Luis Rodrigo

  82. CD4 Responses in the Setting or Suboptimal Virological Responses to Antiretroviral Therapy: Features, Outcomes, and Associated Factors

    Article • AIDS Research and Human Retroviruses, July 2009, Mary Ann Liebert Inc

    Dr Victor Asensi

  83. 227 NON-CIRRHOTIC PORTAL HYPERTENSION IN HIV-INFECTED PATIENTS

    Article • Journal of Hepatology, April 2009, Elsevier

    Dr Victor Asensi, Dr. Vicente Soriano

  84. The influence of the patients’ educational levels on socioeconomic, clinical, immunological and virological endpoints

    Article • AIDS Care, April 2009, Taylor & Francis

    Dr Victor Asensi

  85. Didanosine, Lamivudine, and Efavirenz versus Zidovudine, Lamivudine, and Efavirenz for the Initial Treatment of HIV Type 1 Infection: Final Analysis (48 Weeks) of a Prospective, Randomized, Noninferiority Clinical Trial, GESIDA 3903

    Article • Clinical Infectious Diseases, October 2008, Oxford University Press (OUP)

    Dr Victor Asensi

  86. In vivo treatment with anti B-220 monoclonal antibody affects T and B cell differentiation

    Article • Clinical & Experimental Immunology, June 2008, Wiley

    Dr Victor Asensi

  87. Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin

    Article • Journal of Viral Hepatitis, May 2008, Wiley

    Dr Victor Asensi, Dr. Vicente Soriano

  88. Autoregulation mechanism of human neutrophil apoptosis during bacterial infection☆

    Article • Molecular Immunology, April 2008, Elsevier

    Dr Victor Asensi

  89. IL-1β (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome

    Article • Genetics in Medicine, March 2008, Nature

    Dr Victor Asensi

  90. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments

    Article • Journal of Antimicrobial Chemotherapy, February 2008, Oxford University Press (OUP)

    Dr Victor Asensi

  91. Efficacy and Safety of a Once Daily Regimen with Efavirenz, Lamivudine, and Didanosine, with and without Food, as Initial Therapy for HIV Infection: The ELADI Study

    Article • AIDS Research and Human Retroviruses, October 2007, Mary Ann Liebert Inc

    Dr Victor Asensi, Dr. Vicente Soriano

  92. Role of Weight-Based Ribavirin Dosing and Extended Duration of Therapy in Chronic Hepatitis C in HIV-Infected Patients: The PRESCO Trial

    Article • AIDS Research and Human Retroviruses, August 2007, Mary Ann Liebert Inc

    Dr Victor Asensi, Dr. Vicente Soriano

  93. Factors Associated with Poor Immunologic Responses Despite Viral Suppression in Markedly Immunosuppressed Patients

    Article • AIDS Patient Care and STDs, June 2007, Mary Ann Liebert Inc

    Dr Victor Asensi

  94. Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART

    Article • AIDS, April 2007, Wolters Kluwer Health

    Dr Victor Asensi

  95. [591] IMPACT OF ANEMIA AND ZIDOVUDINE USE ON SUSTAINED VIROLOGICAL RESPONSE IN A TRIAL OF PEGYLATED INTERFERON PLUS RIBAVIRIN IN HIV/HCV-COINFECTED PATIENTS

    Article • Journal of Hepatology, April 2007, Elsevier

    Dr Victor Asensi, Dr. Vicente Soriano

  96. Bax gene G(-248)A promoter polymorphism is associated with increased lifespan of the neutrophils of patients with osteomyelitis

    Article • Genetics in Medicine, April 2007, Nature

    Dr Victor Asensi

  97. P1345 Multidrug-resistant Acinetobacter baumannii prosthetic joint infection treated with colistin

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Dr Victor Asensi

  98. The NOS3 (27-bp repeat, intron 4) polymorphism is associated with susceptibility to osteomyelitis

    Article • Nitric Oxide, February 2007, Elsevier

    Dr Victor Asensi

  99. Cervical lipomatosis in HIV-infected patients: a case?control study

    Article • HIV Medicine, January 2007, Wiley

    Dr Victor Asensi

  100. Association between Physical and Echographic Fat Thickness Assessments and a Lipodystrophy Grading Scale in Lipodystrophic HIV Patients: Practical Implications

    Article • AIDS Research and Human Retroviruses, September 2006, Mary Ann Liebert Inc

    Dr Victor Asensi

  101. Post-surgical enterococcal meningitis: Clinical and epidemiological study of 20 cases

    Article • Scandinavian Journal of Infectious Diseases, August 2006, Taylor & Francis

    Dr Victor Asensi

  102. Influence of HCV Genotype in Isolated Presence of Antibody to Hepatitis B Core Antigen in Patients With HIV Coinfection

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2006, Wolters Kluwer Health

    Dr Victor Asensi

  103. The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for Gram-negative and haematogenous osteomyelitis

    Article • Clinical & Experimental Immunology, March 2006, Wiley

    Dr Victor Asensi

  104. Recomendaciones de GEAM/SPNS sobre el tratamiento de las alteraciones metabólicas y morfológicas en el paciente con infección por VIH

    Article • Enfermedades Infecciosas y Microbiología Clínica, February 2006, Elsevier

    Dr Victor Asensi

  105. Reply to Gulizia et al

    Article • Clinical Infectious Diseases, January 2005, Oxford University Press (OUP)

    Dr Victor Asensi

  106. Estudio comparativo de la meningitis posquirúrgica por Staphylococcus aureus sensible y resistente a meticilina

    Article • Medicina Clínica, January 2005, Elsevier

    Dr Victor Asensi

  107. Hepatocellular carcinoma in HIV-infected patients

    Article • AIDS, November 2004, Wolters Kluwer Health

    Dr Victor Asensi, Dr. Vicente Soriano

  108. Isolated Presence of Antibody to Hepatitis B Core Antigen in Patients Coinfected With HIV

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2004, Wolters Kluwer Health

    Dr Victor Asensi

  109. Perirenal Fat Diameter Measured by Echography Could Be an Early Predictor of Lipodystrophy in HIV Type 1--Infected Patients Receiving Highly Active Antiretroviral Therapy

    Article • Clinical Infectious Diseases, July 2004, Oxford University Press (OUP)

    Dr Victor Asensi

  110. In Vivo Interleukin-6 Protects Neutrophils from Apoptosis in Osteomyelitis

    Article • Infection and Immunity, July 2004, ASM Journals

    Dr Victor Asensi

  111. Grado de replicación del virus de la hepatitis C y aparición de hepatotoxicidad por nevirapina en pacientes con infección por el VIH

    Article • Medicina Clínica, March 2004, Elsevier

    Dr Victor Asensi

  112. Grado de replicación del virus de la hepatitis C y aparición de hepatotoxicidad por nevirapina en pacientes con infección por el VIH

    Article • Medicina Clínica, January 2004, Elsevier

    Dr Victor Asensi

  113. Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus–Infected Patients with Chronic Hepatitis C: A European Collaborative Study

    Article • Clinical Infectious Diseases, January 2004, Oxford University Press (OUP)

    Dr Victor Asensi, Dr. Vicente Soriano

  114. Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations

    Article • Journal of Viral Hepatitis, January 2004, Wiley

    Dr Victor Asensi, Dr. Vicente Soriano

  115. Treatment of Chronic Hepatitis C in HIV-Infected Patients with Interferon α -2b Plus Ribavirin

    Article • AIDS Research and Human Retroviruses, December 2003, Mary Ann Liebert Inc

    Dr Victor Asensi, Dr. Vicente Soriano

  116. Factors Influencing the Development of Lipodystrophy in Human Immunodeficiency Virus-infected Patients

    Article • Scandinavian Journal of Infectious Diseases, May 2003, Taylor & Francis

    Dr Victor Asensi

  117. IL-1α (− 889) promoter polymorphism is a risk factor for osteomyelitis

    Article • American Journal of Medical Genetics Part A, April 2003, Wiley

    Dr Victor Asensi

  118. An open-label, multicenter study of efficacy and safety of peginterferon alfa-2a/ribavirin in HIV/HCV coinfection

    Article • Journal of Hepatology, April 2003, Elsevier

    Dr Victor Asensi

  119. Histological damage in liver biopsy specimens from 492 HIV-HCV co-infected patients: A European collaborative study

    Article • Journal of Hepatology, April 2003, Elsevier

    Dr Victor Asensi, Dr. Vicente Soriano

  120. Hepatitis C Virus in Patients With HIV Infection and Lipodystrophy

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, March 2003, Wolters Kluwer Health

    Dr Victor Asensi

  121. Eikenella corrodens Brain Abscess after Repeated Periodontal Manipulations Cured with Imipenem and Neurosurgery

    Article • Infection, August 2002, Springer Science + Business Media

    Dr Victor Asensi

  122. Triglyceride increase can predict lipodystrophy in HIV patients under highly active antiretroviral therapy

    Article • AIDS, July 2002, Wolters Kluwer Health

    Dr Victor Asensi

  123. Efficacy and safety of combination therapy with interferon plus ribavirin in HIV-infected patients with chronic hepatitis C

    Article • Journal of Hepatology, April 2002, Elsevier

    Dr Victor Asensi, Dr. Vicente Soriano

  124. AIDS-related Kaposi's sarcoma with chylothorax and pericardial involvement satisfactorily treated with liposomal doxorubicin

    Article • AIDS, March 2002, Wolters Kluwer Health

    Dr Victor Asensi

  125. Interrupción del tratamiento antirretroviral en la práctica clínica

    Article • Medicina Clínica, January 2002, Elsevier

    Dr Victor Asensi

  126. Meningitis por Streptococcus suis. A propósito de dos casos y revisión de la literatura

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2001, Elsevier

    Dr Victor Asensi

  127. Meningitis postquirúrgica por Acinetobacter baumannii: estudio de 22 casos y revisión de la literatura

    Article • Revista Clínica Española, January 2001, Elsevier

    Dr Victor Asensi

  128. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C

    Article • The American Journal of Gastroenterology, January 2001, Nature

    Dr Victor Asensi, Dr. Vicente Soriano

  129. Mycobacterium avium Complex Cervical Lymphadenitis in an Immunocompetent Adult Patient

    Article • Journal of Infection, September 2000, Elsevier

    Dr Victor Asensi

  130. Visceral Leishmaniasis and Other Severe Infections in an Adult Patient with p47- phox -Deficient Chronic Granulomatous Disease

    Article • Infection, May 2000, Springer Science + Business Media

    Dr Victor Asensi

  131. Meningitis postquirúrgica por Pseudomonas aeruginosa: estudio de 15 casos y revisión de la literatura

    Article • Revista Clínica Española, January 2000, Elsevier

    Dr Victor Asensi

  132. Successful intrathecal ethanol block for intractable spasticity of AIDS-related progressive multifocal leukoencephalopathy

    Article • Spinal Cord, June 1999, Nature

    Dr Victor Asensi

  133. Lamivudine for chronic hepatitis B and HIV co-infection

    Article • AIDS, May 1999, Wolters Kluwer Health

    Dr Victor Asensi

  134. Cytomegalovirus Antigenemia Surveillance in the Treatment of Cytomegalovirus Disease in AIDS Patients

    Article • Journal of Chemotherapy, January 1999, Taylor & Francis

    Dr Victor Asensi

  135. Prosthetic joint infection byPasteurella multocida

    Article • European Journal of Clinical Microbiology & Infectious Diseases, August 1997, Springer Science + Business Media

    Dr Victor Asensi

  136. Bactericidal Effect of ADP and Acetic Acid on Bacillus subtilis

    Article • Current Microbiology, January 1997, Springer Science + Business Media

    Dr Victor Asensi

  137. Imipenem therapy of brain abscesses

    Article • European Journal of Clinical Microbiology & Infectious Diseases, August 1996, Springer Science + Business Media

    Dr Victor Asensi

  138. Answer to Photo Quiz

    Article • Clinical Infectious Diseases, April 1996, Oxford University Press (OUP)

    Dr Victor Asensi

  139. Therapy of brain abscess with impienem—a safe therapeutic choice?

    Article • Journal of Antimicrobial Chemotherapy, January 1996, Oxford University Press (OUP)

    Dr Victor Asensi

  140. Myasthenia Gravis and Systemic Lupus Erythematosus in Association with Human Immunodeficiency Virus Infection

    Article • Clinical Infectious Diseases, June 1995, Oxford University Press (OUP)

    Dr Victor Asensi

  141. Clinical Value of Blood Cultures for Detection of Toxoplasma gondii in Human Immunodeficiency Virus-Seropositive Patients with and without Cerebral Lesions on Computerized Tomography

    Article • Clinical Infectious Diseases, September 1993, Oxford University Press (OUP)

    Dr Victor Asensi

  142. Synergistic Effect of Human Lysozyme Plus Ampicillin or  -Lysin on the Killing of Listeria monocytogenes

    Article • The Journal of Infectious Diseases, March 1991, Oxford University Press (OUP)

    Dr Victor Asensi

  143. In vivoInfluence of the Anti-B220 Monoclonal Antibody Administration on the T Cell Differentiation in Mice

    Article • Microbiology and Immunology, April 1989, Wiley

    Dr Victor Asensi